Drug information for MITOMYCIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
20MG/VIAL
Discontinued
MITOMYCIN
Mitomycin
HOSPIRA
64106
INJECTABLE; INJECTION
20MG/VIAL
Prescription
AP
MITOMYCIN
Mitomycin
BEDFORD
64117
INJECTABLE; INJECTION
5MG/VIAL
Prescription
AP
MITOMYCIN
Mitomycin
BEDFORD
"
INJECTABLE; INJECTION
20MG/VIAL
Prescription
AP (Reference Drug)
MITOMYCIN
Mitomycin
ACCORD HLTHCARE
64144
1998-04-30 Letter
INJECTABLE; INJECTION
40MG/VIAL
Prescription
AP (Reference Drug)
MITOMYCIN
Mitomycin
ACCORD HLTHCARE
"
INJECTABLE; INJECTION
5MG/VIAL
Prescription
AP (Reference Drug)
MITOMYCIN
Mitomycin
ACCORD HLTHCARE
"
INJECTABLE; INJECTION
20MG/VIAL
Prescription
AP
MITOMYCIN
Mitomycin
BAXTER HLTHCARE
64180
1999-12-23 Letter
INJECTABLE; INJECTION
5MG/VIAL
Prescription
AP
MITOMYCIN
Mitomycin
BAXTER HLTHCARE
"
Drug Adverse Effects information for MITOMYCIN
Role code
Indications
Reaction
# Reports
PS
ANAL CANCER
DIARRHOEA
2
PS
ANAL CANCER
HAEMOLYTIC URAEMIC SYNDROME
2
PS
ANAL CANCER
PYREXIA
2
PS
ANAL CANCER
STOMATITIS
2
PS
ANAL CANCER
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
PS
ANAL CANCER
TRISMUS
2
PS
ANAL CANCER
WEIGHT DECREASED
2
PS
ANAL CANCER RECURRENT
HAEMOLYTIC URAEMIC SYNDROME
2
PS
ANAL CANCER RECURRENT
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
PS
BLADDER CANCER
BLISTER
1
PS
BLADDER CANCER
CONTRACTED BLADDER
1
PS
BLADDER CANCER
CYSTITIS
1
PS
BLADDER CANCER
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
1
PS
BLADDER CANCER
RASH GENERALISED
2
PS
BLADDER CANCER
URINARY TRACT INFECTION
1
PS
BLADDER TRANSITIONAL CELL CARCINOMA
CHEMICAL CYSTITIS
2
PS
BLADDER TRANSITIONAL CELL CARCINOMA
SUPRAPUBIC PAIN
2
PS
CONJUNCTIVAL MELANOMA
BLINDNESS
1
PS
CONJUNCTIVAL MELANOMA
EYE DISORDER
1
PS
CONJUNCTIVAL MELANOMA
OFF LABEL USE
1
PS
HEPATIC NEOPLASM MALIGNANT
BILIARY TRACT DISORDER
4
PS
HEPATIC NEOPLASM MALIGNANT
BILOMA
2
PS
HEPATIC NEOPLASM MALIGNANT
BLOOD CHLORIDE DECREASED
2
PS
HEPATIC NEOPLASM MALIGNANT
BLOOD SODIUM DECREASED
2
PS
HEPATIC NEOPLASM MALIGNANT
GASTRIC STENOSIS
3
PS
HEPATIC NEOPLASM MALIGNANT
PLATELET COUNT DECREASED
2
PS
HEPATIC NEOPLASM MALIGNANT
WHITE BLOOD CELL COUNT DECREASED
2
PS
MALIGNANT MELANOMA
CYSTOID MACULAR OEDEMA
4
PS
METASTASES TO LYMPH NODES
HAEMOLYTIC URAEMIC SYNDROME
2
PS
METASTASES TO LYMPH NODES
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FAILURE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOTOXICITY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
OFF LABEL USE
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
PANCREATITIS ACUTE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PSEUDOCYST
1
PS
TRABECULECTOMY
CORNEAL EPITHELIAL MICROCYSTS
1
PS
TRABECULECTOMY
OFF LABEL USE
1
PS
TRANSITIONAL CELL CARCINOMA
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
1
PS
TRANSITIONAL CELL CARCINOMA
RASH GENERALISED
1
PS
VISUAL ACUITY REDUCED
CORNEAL SCAR
2
PS
VISUAL ACUITY REDUCED
VISUAL ACUITY REDUCED
2
SS
ANAL CANCER
HAEMOLYTIC URAEMIC SYNDROME
4
SS
ANAL CANCER
RASH
2
SS
ANAL CANCER
THROMBOCYTOPENIA
2
SS
ANAL CANCER
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
SS
ANAL CANCER RECURRENT
HAEMOLYTIC URAEMIC SYNDROME
2
SS
ANAL CANCER RECURRENT
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
SS
BLADDER TRANSITIONAL CELL CARCINOMA
CHEMICAL CYSTITIS
1
SS
BREAST CANCER
CARDIAC CIRRHOSIS
20
SS
BREAST CANCER
HEPATIC CIRRHOSIS
30
SS
BREAST CANCER
HEPATIC FAILURE
94
SS
BREAST CANCER
LIVER SCAN ABNORMAL
30
SS
BREAST CANCER METASTATIC
ASCITES
14
SS
BREAST CANCER METASTATIC
HEPATIC CIRRHOSIS
86
SS
BREAST CANCER METASTATIC
HEPATIC FAILURE
86
SS
BREAST CANCER METASTATIC
PORTAL HYPERTENSION
14
SS
CHEMOTHERAPY
HEPATIC FAILURE
2
SS
CHEMOTHERAPY
HEPATIC NEOPLASM MALIGNANT
4
SS
CHEMOTHERAPY
NEOPLASM PROGRESSION
4
SS
CHEMOTHERAPY
OESOPHAGEAL VARICES HAEMORRHAGE
2
SS
CHEMOTHERAPY
OFF LABEL USE
4
SS
CHEMOTHERAPY
TUMOUR THROMBOSIS
4
SS
HORMONE REPLACEMENT THERAPY
CARDIAC CIRRHOSIS
1
SS
HORMONE REPLACEMENT THERAPY
HEPATIC FAILURE
1
SS
HORMONE THERAPY
CARDIAC CIRRHOSIS
9
SS
HORMONE THERAPY
HEPATIC FAILURE
9
SS
METASTASES TO LYMPH NODES
HAEMOLYTIC URAEMIC SYNDROME
2
SS
METASTASES TO LYMPH NODES
THROMBOTIC THROMBOCYTOPENIC PURPURA
2
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
HEPATIC NEOPLASM MALIGNANT
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
NEOPLASM PROGRESSION
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
OFF LABEL USE
1
SS
PERCUTANEOUS ETHANOL INJECTION THERAPY
TUMOUR THROMBOSIS
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATITIS
2
SS
REGIONAL CHEMOTHERAPY
HEPATIC FAILURE
1
SS
REGIONAL CHEMOTHERAPY
HEPATIC NEOPLASM MALIGNANT
2
SS
REGIONAL CHEMOTHERAPY
NEOPLASM PROGRESSION
2
SS
REGIONAL CHEMOTHERAPY
OESOPHAGEAL VARICES HAEMORRHAGE
1
SS
REGIONAL CHEMOTHERAPY
OFF LABEL USE
2
SS
REGIONAL CHEMOTHERAPY
TUMOUR THROMBOSIS
2
SS
SARCOMA
ELECTROLYTE IMBALANCE
7
SS
SARCOMA
EMBOLISM VENOUS
7
SS
SARCOMA
WOUND COMPLICATION
13
C
ABDOMINAL PAIN
BLADDER CANCER
1
C
ANAL CANCER
PHARYNGEAL INFLAMMATION
1
C
BLADDER CANCER
BLADDER CANCER
1
C
CROHN'S DISEASE
BLADDER CANCER
3
C
DIARRHOEA
BLADDER CANCER
1
C
GLAUCOMA
CORNEAL EROSION
1
C
GLAUCOMA
INTRAOCULAR PRESSURE INCREASED
1
C
NUTRITIONAL SUPPORT
ANAPHYLACTIC SHOCK
1
Ads by Google